Atea Pharmaceuticals, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Atea Pharmaceuticals, Inc. reported Cash And Cash Equivalents At Carrying Value of $95.71 million for the year ending 2025.

  • Atea Pharmaceuticals, Inc. showed an increase of +47.9% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Atea Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
  • XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 8 years of available data (2018 to 2025), Atea Pharmaceuticals, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 177.5%.
  • Historical annual values: Fiscal year 2025: $95.71 million | Fiscal year 2024: $64.70 million | Fiscal year 2023: $143.82 million | Fiscal year 2022: $188.46 million | Fiscal year 2021: $764.38 million | Fiscal year 2020: $850.12 million | Fiscal year 2019: $21.66 million | Fiscal year 2018: $34.49 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: